While these pharma stocks have steady cash flows and revenues, there’s still plenty of growth left in the tank from new drugs in development. These dividend-paying biotech stocks could be the best way to play the sector. Their dividends make them less volatile than the lotto tickets, but there’s still plenty of upside potential as well. And with the overall market down in the dumps, many of these strong dividend-paying biotech stocks are now trading for peanuts. That means investors have plenty of opportunities to score some great deals. With that, here are five dividend-paying biotech stocks you need to scoop up today...
There’s no denying that Amgen (NASDAQ:AMGN) is king of biotech stocks. Like Amgen, Gilead Sciences (NASDAQ:GILD) built its impressive dividend on the back of several key blockbuster drugs. At first blush, the next of our dividend stocks, French drug producer Sanofi (NYSE:SNY), looks more like a traditional pharmaceutical firm. Truth be told, Allergan (NYSE:AGN) could be the biggest bargain of any stock on this list. A big-time approval can do wonders for your future. Just ask AbbVie Inc. (NASDAQ:ABBV).
Source: InvestorPlace
Related Articles:
- Building Yield: 6 Consumer Goods Dividend Stocks
- Why Dividend Growth Stocks Are Evil
- 4 Higher-Yielding Financial Services Stocks With Rising Dividends
- 5 Higher Yield Dividend Growth Stocks
- Successful Investors Take The Emotion Out
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Stocks that offer big dividend yields are often backed by businesses that are going through rough patches and experiencing significant downt...
-
Showing resilience during a tough week was a group of stocks that has not been heard from much in the past two years. A group that has been ...
-
With the calendar turning over to 2019, many of the trends causing the rise in volatility aren’t stopping. To that end, making a calculated ...
-
This company has become an income machine for investors over the past three decades, thanks in large part to the 132 consecutive dividends i...
-
Many dividend stocks tumbled over the past year, since conservative investors often shift from high-yielding stocks to bonds when interest r...
-
If you want to find good deals this holiday season, forget the department stores. Instead, go to the stock market. Due to the lackluster per...
-
Because we're expected to live longer than those just a generation or two removed from us, we'll need income during our retirement f...
-
The yield is 9.07%, with 1.14X coverage in Q3 '18. EVA has a $7.4B backlog that's contracted through 2025. Management expects EBITDA...
-
Even though GDP is growing nicely, consumer spending is red hot and unemployment is low, the stocks that are outperforming are all ones we’d...
-
For the most part, stock market investors love the technology sector. While tech stocks were hit particularly hard during the latest market ...
0 comments
Post a Comment
Post a Comment